MWNA
AGN

Marshall Wace North America’s Allergan Inc AGN Stock Holding History

Marshall Wace North America’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$6.25M Buy
56,312
+6,377
+13% +$609K 0.13% 170
2013
Q3 		$4.52M Sell
49,935
-129,640
-72% -$11.6M 0.14% 179
2013
Q2 		$15.1M Buy
+179,575
New +$18.6M 1.19% 6

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Marshall Wace North America's AGN Position: Q4 2013 in Review

Marshall Wace North America increased its Allergan Inc (AGN) stake by 13% in Q4 2013, buying an estimated $609K and bringing the position to 56,312 shares worth $6.25M. The position accounts for 0.13% of the portfolio, ranked #170.

Marshall Wace North America first reported a position in AGN in Q2 2013 and has held it in 3 quarters since. The position peaked at $15.1M in Q2 2013. 709 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Marshall Wace North America held 56,312 shares of Allergan Inc worth $6.25M as of Q4 2013.
  • Marshall Wace North America bought 6,377 Allergan Inc shares in Q4 2013, an estimated $609K.
  • Allergan Inc made up 0.13% of Marshall Wace North America's portfolio in Q4 2013, its #170 holding.
  • Marshall Wace North America first reported a position in Allergan Inc in Q2 2013 and has held it in 3 quarters since.
  • Marshall Wace North America's Allergan Inc position peaked at $15.1M in Q2 2013.
  • 709 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.